Anbio Biotechnology

Develops and supplies in vitro diagnostic solutions for human and veterinary markets.

NNNN | NDAQ

Overview

Corporate Details

ISIN(s):: KYG0367B1059
LEI:
Country:: United States of America
Address:: FRIEDRICH-EBERT-ANLAGE 49, 60308 FRANKFURT AM MAIN
Website:: https://anbiobiotechnology.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Anbio Biotechnology is a global medical technology company founded in 2021 that specializes in in vitro diagnostics (IVD). The company develops, manufactures, and supplies a diverse portfolio of diagnostic products for over-the-counter (OTC), point-of-care (POCT), and laboratory use, serving both human and veterinary markets. Its solutions are designed to detect a wide range of biomarkers across critical medical fields such as infectious diseases, cancer, cardiovascular diseases, and diabetes. Anbio utilizes five core technology platforms: Chemiluminescence Immunoassay (ChLIA), Lateral Flow Immunoassay (LFIA), Fluorescent Immunoassay (FIA), Polymerase Chain Reaction (PCR), and Loop-mediated Isothermal Amplification (LAMP). The company's mission is to advance personalized and decentralized diagnostics to improve healthcare outcomes worldwide.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Anbio Biotechnology filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Anbio Biotechnology

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Anbio Biotechnology via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Clearside Biomedical, Inc. Developing therapies for back-of-the-eye diseases via proprietary suprachoroidal delivery.	United States of America	CLSD
Clene Inc. Developing nanocrystal therapies for neurodegenerative diseases like ALS and MS.	United States of America	CLNN
Climb Bio, Inc. Clinical-stage biotech developing monoclonal antibodies for immune-mediated diseases.	United States of America	CLYM
CMG Pharmaceutical Co., Ltd. Develops and manufactures prescription drugs, specializing in Oral Thin Film (OTF) technology.	South Korea	058820
Cocrystal Pharma, Inc. Develops novel antiviral drugs for influenza, coronaviruses, norovirus, and hepatitis C.	United States of America	COCP
Co-Diagnostics, Inc. Develops patented PCR solutions for accurate infectious disease diagnostics.	United States of America	CODX
co.don AG Develops personalized cartilage cell transplants for minimally invasive joint repair.	Germany	CNW
Coeptis Therapeutics Holdings, Inc. Develops cell therapy platforms for cancer, autoimmune, and infectious diseases.	United States of America	COEP
COGNITION THERAPEUTICS INC Clinical-stage biopharma developing small-molecule drugs for Alzheimer's and dementia.	United States of America	CGTX
Coherus Oncology, Inc. Commercial-stage biopharma developing immuno-oncology therapies for hard-to-treat cancers.	United States of America	CHRS